Latest news
As FDA makes Lipfendra poster child of CNPV pilot, Merck charts long-term path for first PCSK9 pill - Fierce PharmaFierce Pharma · Tue, 04 Aug 2026 18:38:51 GMTFierce Pharma Asia—Legend CEO exits; Merck’s hush-hush PD-1xVEGF plan; Otsuka’s novel ADHD nod - Fierce PharmaFierce Pharma · Fri, 31 Jul 2026 07:00:00 GMTMerck posts—then pulls—trial plan for PD-1xVEGF and TROP2 ADC combination - fiercebiotech.comfiercebiotech.com · Wed, 29 Jul 2026 07:00:00 GMT